Brain Tumor

Oncology
2
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Blue Earth Therapeutics
1 program
1
[18F]FLTPhase 1/21 trial
Active Trials
NCT03276676TerminatedEst. Aug 2023
Amgen
AmgenTHOUSAND OAKS, CA
1 program
1
SotorasibPhase 11 trial
Active Trials
NCT06807619Recruiting16Est. Jan 2028
Inbrain Neuroelectronics
Inbrain NeuroelectronicsSpain - Barcelona
1 program
INBRAIN Graphene Cortical InterfaceN/A
Olympus
OlympusPA - Center Valley
1 program
Orbeye surgical videomicroscopeN/A1 trial
Active Trials
NCT04055688Completed20Est. Feb 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Blue Earth Therapeutics[18F]FLT
AmgenSotorasib
OlympusOrbeye surgical videomicroscope

Clinical Trials (3)

Total enrollment: 36 patients across 3 trials

[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors

Start: Sep 2018Est. completion: Aug 2023
Phase 1/2Terminated

A Study of Sotorasib in People With Brain Tumors

Start: Jan 2025Est. completion: Jan 202816 patients
Phase 1Recruiting
NCT04055688OlympusOrbeye surgical videomicroscope

Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas

Start: Aug 2019Est. completion: Feb 202120 patients
N/ACompleted

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 36 patients
4 companies competing in this space